Delivery Order SPE2DB20D2014-SPE2DB25FB04C

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,135.82 firm fixed-price delivery order is for the supply of NOVOLIN N 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The award has an ultimate completion date of February 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of NovLog 100 Unit/mL FlexPen 3mL insulin products to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,883.30 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,767.98 Firm Fixed Price delivery order is for the supply of NOVOLIN R 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,473.04 firm fixed price delivery order is for the supply of Novolin N 100 Unit/mL Flexpen 3mL, a prescription insulin product. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued up to $999,999,999.00 through...
This federal contract award is for the delivery of Novolin N 100 unit/mL Flexpen 3mL, a type of insulin medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract has a ceiling value of $1,036.40 and a completion date of September 20, 2023. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,152.35 firm fixed-price delivery order is for NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The award has an ultimate completion date of December 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,028.04, is for the delivery of NOVOLIN R 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract is a firm fixed-price delivery order with a period of performance through January 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $1,048.70 firm-fixed-price delivery order is for the supply of NovoCare 100 unit/mL FlexPen 3mL insulin devices. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
This federal contract award, valued at $1,834.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication, with a completion date of February 11, 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB04C
    Delivery Order

The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,758.27 firm fixed-price delivery order is for the supply of NOVOLIN N 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, through its extensive distribution capabilities and broad spectrum of medical commodity procurement across multiple federal agencies.

Generated 5/13/25, 10:12 AM